Teva Pharmaceutical Industries Ltd

Argyle Capital Management, LLC TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

16,200

Value ($000)

506

Weight

0.2%

2013 Q4 - 2025 Q4 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	506	0.2%	16,200	12/31/2025
2025 Q3	10/27/2025	327	0.1%	16,200	9/30/2025
2025 Q2	7/24/2025	272	0.1%	16,200	6/30/2025
2014 Q2	7/25/2014	1,869	0.9%	35,652	6/30/2014
2014 Q1	4/24/2014	1,884	0.9%	35,652	3/31/2014
2013 Q4	1/31/2014	1,461	0.7%	36,452	12/31/2013